Department of Rheumatology Immunology and Allergy, Children's Hospital of Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
Department of Pathology, Children's Hospital of Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
Am J Med Genet A. 2021 Oct;185(10):3146-3152. doi: 10.1002/ajmg.a.62397. Epub 2021 Jun 29.
Interferon-induced with helicase C domain 1 (IFIH1) is a cytosolic sensor of dsRNA that induces an anti-viral Type I interferon (IFN) state. A gain-of-function mutation in IFIH1 can cause increased Type I IFN activity and is clinically associated with Aicardi-Goutières syndrome (AGS). AGS is a multisystem disease, characterized as an early-onset progressive encephalopathy with basal ganglia calcification and systemic lupus erythematosus-like features. Gastrointestinal manifestation is rare in AGS patients. We described a 10-year-old female patient with a heterozygous IFIH1 gene mutation who presented with gastrointestinal colitis, cystitis and very severe diarrhea as initial major manifestations of AGS. Proteinuria with high titer of antinuclear antibody and anti-double-stranded DNA was found in this patient. She also had growth retardation and a history of seizures (about two episodes each year) but without attacks until 7 years old. Serum cytokines detected by flow cytometry indicated extremely high level of interleukin 6 (1970.1 pg/ml) and IFN-α (204.1 pg/ml). A contrast-enhanced CT scan of the whole abdomen and an intestinal hydro-MRI indicated that the walls of her stomach, small bowel, colon, and bladder were in various degrees of edema and thickened states. Whole exome sequencing analysis indicated that she harbors an IFIH1 heterozygous mutation (c.2336G > A (p.R779H)) in both blood and intestinal samples. Abundant inflammatory cells infiltration into the intestinal epithelium was observed by immunohistochemical staining. Positive staining of caspase 4 and caspase 5 suggested that the signaling pathway of pyroptosis was involved in the mechanism of intestinal inflammation in AGS. Diarrhea was significantly improved after steroids and intravenous immunoglobulin treatments. Gastrointestinal colitis and cystitis can be rare manifestations of AGS with IFIH1 mutation. Caspase and its related inflammasome pathway may involve in the pathogenesis of AGS.
干扰素诱导的含有解旋酶 C 结构域的蛋白 1(IFIH1)是一种细胞质双链 RNA 传感器,可诱导抗病毒的 I 型干扰素(IFN)状态。IFIH1 的功能获得性突变可导致 I 型 IFN 活性增加,临床上与 Aicardi-Goutières 综合征(AGS)相关。AGS 是一种多系统疾病,其特征为早发性进行性脑病,伴基底节钙化和系统性红斑狼疮样特征。AGS 患者的胃肠道表现罕见。我们描述了一位 10 岁女性患者,其携带 IFIH1 基因突变杂合子,表现为胃肠道结肠炎、膀胱炎和非常严重的腹泻,为 AGS 的初始主要表现。该患者还存在蛋白尿、高滴度抗核抗体和抗双链 DNA 抗体,且生长迟缓,有癫痫发作史(每年约 2 次发作),但直到 7 岁时才发作。流式细胞术检测的血清细胞因子表明白细胞介素 6(1970.1 pg/ml)和 IFN-α(204.1 pg/ml)水平极高。全腹部增强 CT 扫描和肠道水 MRI 表明,她的胃、小肠、结肠和膀胱壁均存在不同程度的水肿和增厚。全外显子组测序分析表明,她的血液和肠道样本中均存在 IFIH1 杂合突变(c.2336G>A(p.R779H))。免疫组织化学染色显示,大量炎性细胞浸润肠上皮。半胱氨酸蛋白酶 4 和半胱氨酸蛋白酶 5 的阳性染色提示,细胞焦亡信号通路可能参与 AGS 肠道炎症的发病机制。皮质类固醇和静脉注射免疫球蛋白治疗后,腹泻明显改善。伴有 IFAH1 突变的 AGS 可表现为胃肠道结肠炎和膀胱炎,且罕见。半胱氨酸蛋白酶及其相关炎性小体通路可能参与 AGS 的发病机制。